Kimberly-Clark (KMB) Reports Q3 Earnings: What Key Metrics Have to Say

30.10.25 14:30 Uhr

Werte in diesem Artikel
Aktien

105,04 EUR 3,34 EUR 3,28%

Indizes

17.884,5 PKT -174,8 PKT -0,97%

6.857,0 PKT -33,6 PKT -0,49%

Kimberly-Clark (KMB) reported $4.15 billion in revenue for the quarter ended September 2025, representing a year-over-year decline of 16.2%. EPS of $1.82 for the same period compares to $1.83 a year ago.The reported revenue represents a surprise of +1.75% over the Zacks Consensus Estimate of $4.08 billion. With the consensus EPS estimate being $1.45, the EPS surprise was +25.52%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Kimberly-Clark performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Net Sales - NA - Volume impact - YoY change: 2.6% versus the four-analyst average estimate of 0.8%.Net Sales - Consolidated - Organic - YoY change: 2.5% versus 1.3% estimated by four analysts on average.Net Sales - NA - Mix/Other impact - YoY change: -0.5% compared to the 0.3% average estimate based on four analysts.Net Sales - NA - Divestitures & Business Exits - YoY change: -3.3% versus the four-analyst average estimate of -3.7%.Net Sales - NA - Organic - YoY change: 2.7% versus 0.7% estimated by four analysts on average.Net Sales - IPC - Volume impact - YoY change: 2% versus 3.8% estimated by four analysts on average.Net Sales - IPC - Mix/Other impact - YoY change: 1.6% versus the four-analyst average estimate of 0.7%.Net Sales - IPC - Net Price impact - YoY change: -1.5% versus the four-analyst average estimate of -2.1%.Net Sales - NA - Net Price impact - YoY change: 0.4% compared to the -0.3% average estimate based on four analysts.Net Sales - IPC - Currency Translation - YoY change: -0.1% compared to the -1.6% average estimate based on four analysts.Net Sales- IPC: $1.44 billion versus the four-analyst average estimate of $1.42 billion.Net Sales- NA: $2.71 billion versus the four-analyst average estimate of $2.65 billion.View all Key Company Metrics for Kimberly-Clark here>>>Shares of Kimberly-Clark have returned -5.3% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Kimberly-Clark Corporation (KMB): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks

In eigener Sache

Übrigens: Kimberly-Clark und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Ausgewählte Hebelprodukte auf Clark

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Clark

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Quelle: Zacks

Nachrichten zu Kimberly-Clark Corp.

Wer­bung

Analysen zu Kimberly-Clark Corp.

DatumRatingAnalyst
14.12.2017Kimberly-Clark HoldDeutsche Bank AG
09.01.2017Kimberly-Clark Equal WeightBarclays Capital
25.10.2016Kimberly-Clark HoldDeutsche Bank AG
25.10.2016Kimberly-Clark NeutralB. Riley & Co., LLC
25.10.2016Kimberly-Clark Sector PerformRBC Capital Markets
DatumRatingAnalyst
22.10.2015Kimberly-Clark BuyDeutsche Bank AG
15.09.2015Kimberly-Clark BuyDeutsche Bank AG
13.05.2015Kimberly-Clark OverweightBarclays Capital
02.04.2015Kimberly-Clark Market PerformBMO Capital Markets
02.01.2015Kimberly-Clark OutperformBMO Capital Markets
DatumRatingAnalyst
14.12.2017Kimberly-Clark HoldDeutsche Bank AG
09.01.2017Kimberly-Clark Equal WeightBarclays Capital
25.10.2016Kimberly-Clark HoldDeutsche Bank AG
25.10.2016Kimberly-Clark NeutralB. Riley & Co., LLC
25.10.2016Kimberly-Clark Sector PerformRBC Capital Markets
DatumRatingAnalyst
09.12.2009Kimberley-Clark underweight (Update)Barclays Capital
09.12.2009Kimberley-Clark underweightBarclays Capital
16.07.2008Kimberly-Clark below averageCaris & Company, Inc.
28.05.2008Kimberly-Clark below averageCaris & Company, Inc.
15.05.2008Kimberly-Clark below averageCaris & Company, Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Kimberly-Clark Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen